(Alliance News) - Imaging Biometrics Ltd on Thursday noted the use of its Functional Tumor Burden mapping technology in a glioblastoma clinical trial at Cooper University's MD Anderson Cancer Center.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback